1. Home
  2. ELME vs QNCX Comparison

ELME vs QNCX Comparison

Compare ELME & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elme Communities

ELME

Elme Communities

HOLD

Current Price

$2.04

Market Cap

198.2M

Sector

Real Estate

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$0.09

Market Cap

167.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELME
QNCX
Founded
1960
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
167.0M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
ELME
QNCX
Price
$2.04
$0.09
Analyst Decision
Hold
Hold
Analyst Count
3
2
Target Price
$12.67
N/A
AVG Volume (30 Days)
1.4M
14.0M
Earning Date
04-30-2026
05-12-2026
Dividend Yield
741.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$206,360,000.00
N/A
Revenue This Year
$5.03
N/A
Revenue Next Year
$4.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.98
$0.08
52 Week High
$17.68
$4.55

Technical Indicators

Market Signals
Indicator
ELME
QNCX
Relative Strength Index (RSI) 23.19 29.77
Support Level $1.98 $0.08
Resistance Level $2.26 $0.98
Average True Range (ATR) 0.05 0.01
MACD 0.08 0.04
Stochastic Oscillator 29.63 21.56

Price Performance

Historical Comparison
ELME
QNCX

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: